A longitudinal study of antioxidant status in phenylketonuric patients

被引:55
作者
Artuch, R
Colomé, C
Sierra, C
Brandi, N
Lambruschini, N
Campistol, J
Ugarte, D
Vilaseca, MA
机构
[1] Hosp Sant Joan de Deu, Serv Bioquim, Barcelona 09850, Spain
[2] Univ Publ Navarra, Dept Estadist & IO, Pamplona, Spain
关键词
phenylketonuria; selenium; ubiquinone-10; antioxidant enzymes; dietary treatment;
D O I
10.1016/j.clinbiochem.2003.10.017
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To investigate the implications of the three main factors of the antioxidant system reported in relation to oxidative damage in phenylketonuric patients: selenium, ubiquinone-10 (Q10) and antioxidant enzymes over 3 years of metabolic follow-up. Design and methods: Longitudinal study of 46 phenylketonuric patients (age range: 6 months-34 years). Antioxidants were measured by atomic absorption spectrophotometric, chromatographic and spectrophotometric procedures. Results: Plasma selenium concentrations in phenylketonuria (PKU) were not different from those of a healthy population. Decreased plasma Q 10 concentrations were mainly related to the dietary control and the age of patients. Erythrocyte catalase activity was significantly decreased in PKU while the other enzyme activities were not different from those of a healthy population. Conclusions: Selenium status is not impaired in phenylketonuric patients under dietary treatment. Q10 values tend to decrease with increased patient age. Catalase activity was negatively associated with plasma phenylalanine values. (C) 2003 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:198 / 203
页数:6
相关论文
共 28 条
  • [1] Plasma micronutrient concentrations in infants undergoing therapy for phenylketonuria
    Acosta, PB
    Yannicelli, S
    [J]. BIOLOGICAL TRACE ELEMENT RESEARCH, 1999, 67 (01) : 75 - 84
  • [2] Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria
    Artuch, R
    Colomé, C
    Vilaseca, MA
    Sierra, C
    Cambra, FJ
    Lambruschini, N
    Campistol, J
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (03) : 359 - 366
  • [3] Artuch R, 1999, AM J CLIN NUTR, V70, P892
  • [4] MORPHOLOGIC AND HISTOANATOMIC OBSERVATIONS OF THE BRAIN IN UNTREATED HUMAN PHENYLKETONURIA
    BAUMAN, ML
    KEMPER, TL
    [J]. ACTA NEUROPATHOLOGICA, 1982, 58 (01) : 55 - 63
  • [5] CASTILLO M, 1991, MOL CELL BIOCHEM, V105, P21
  • [6] Lipophilic antioxidants in patients with phenylketonuria
    Colomé, C
    Artuch, R
    Vilaseca, MA
    Sierra, C
    Brandi, N
    Lambruschini, N
    Cambra, FJ
    Campistol, J
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 77 (01) : 185 - 188
  • [7] Is there a relationship between plasma phenylalanine and cholesterol in phenylketonuric patients under dietary treatment?
    Colomé, C
    Artuch, R
    Lambruschini, N
    Cambra, FJ
    Campistol, J
    Vilaseca, MA
    [J]. CLINICAL BIOCHEMISTRY, 2001, 34 (05) : 373 - 376
  • [8] Oxidative stress in a phenylketonuria animal model
    Ercal, N
    Aykin-Burns, N
    Gurer-Orhan, H
    McDonald, JD
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (09) : 906 - 911
  • [9] Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection
    Finckh, B
    Kontush, A
    Commentz, J
    Hubner, C
    Burdelski, M
    Kohlschutter, A
    [J]. ANALYTICAL BIOCHEMISTRY, 1995, 232 (02) : 210 - 216
  • [10] Experimental hyperphenylalaninemia provokes oxidative stress in rat brain
    Hagen, MEK
    Pederzolli, CD
    Sgaravatti, AM
    Bridi, R
    Wajner, M
    Wannmacher, CMD
    Wyse, ATS
    Dutra, CS
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1586 (03): : 344 - 352